代谢健康型肥胖成人的亚临床与心血管疾病风险高负担:ARIC研究
该研究基于ARIC队列9477名成人,按代谢健康状态与BMI划分肥胖表型,分析其与亚临床及临床心血管疾病(CVD)的关联。中位随访17年,代谢健康型肥胖者CVD风险仍高于代谢健康正常体重者(HR 1.38),主要由心力衰竭风险驱动(HR 1.65)。可检测的高敏心肌肌钙蛋白T(hs-cTnT≥6 ng/L)在所有表型中均可分层CVD风险。
要点
- 代谢健康型肥胖者CVD风险仍显著高于代谢健康正常体重者。
- 代谢健康型肥胖者心力衰竭风险尤其升高(HR 1.65)。
- hs-cTnT≥6 ng/L可在所有肥胖表型中分层CVD风险。
核心结论
- 代谢健康型肥胖表型与临床CVD超额负担相关,主要由心力衰竭风险超额驱动。
- hs-cTnT有助于在所有肥胖表型中分层CVD风险,即使对看似代谢健康的肥胖个体也是如此。
研究设计与样本
- 对ARIC研究中9477名成人进行横断面和前瞻性分析。
- 使用ATP III标准和BMI定义六种肥胖表型。
- 基线为1990-1992年,中位随访17年。
主要发现
- 基线时平均年龄56岁,56%为女性,23%为黑人,25%可检测到hs-cTnT(≥6 ng/L)。
- 随访期间共发生2603例临床CVD事件。
- 与代谢健康正常体重者相比,代谢健康肥胖者CVD风险HR为1.38(95%CI 1.15-1.67)。
- 代谢健康肥胖者心力衰竭风险HR为1.65(95%CI 1.30-2.09)。
- 可检测hs-cTnT(≥6 ng/L)与更高CVD风险相关,即使在代谢健康正常体重成人中也是如此。
关键数值与推荐
- 代谢健康肥胖:HR 1.38(95%CI 1.15-1.67) for CVD vs 代谢健康正常体重。
- 代谢不健康正常体重:HR 1.51(95%CI 1.30-1.76) for CVD vs 代谢健康正常体重。
- 代谢不健康超重:HR 1.60(95%CI 1.41-1.82) for CVD vs 代谢健康正常体重。
- 代谢不健康肥胖:HR 2.14(95%CI 1.88-2.44) for CVD vs 代谢健康正常体重。
- 代谢健康肥胖:HR 1.65(95%CI 1.30-2.09) for HF vs 代谢健康正常体重。
临床怎么用
- 对代谢健康型肥胖成人也应评估CVD风险,尤其是心力衰竭风险。
- hs-cTnT可作为分层工具,识别代谢健康肥胖中CVD高风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: It is controversial whether adults who are obese but "metabolically healthy" have cardiovascular disease (CVD) risk comparable with that of normal-weight adults. High-sensitivity cardiac troponin T (hs-cTnT), a biomarker of myocardial damage, is useful in characterizing subclinical CVD. We categorized obesity phenotypes and studied their associations with subclinical and clinical CVD and CVD subtypes, including heart failure (HF). RESEARCH DESIGN AND METHODS: We conducted cross-sectional and prospective analyses of 9,477 adults in the Atherosclerosis Risk in Communities (ARIC) study. We used the Adult Treatment Panel III criteria and BMI to define obesity phenotypes as follows: metabolically healthy normal weight, metabolically healthy overweight, metabolically healthy obese, metabolically unhealthy normal weight, metabolically unhealthy overweight, and metabolically unhealthy obese. RESULTS: At baseline (1990-1992), mean age was 56 years, 56% were female, 23% were Black, and 25% had detectable hs-cTnT (≥6 ng/L). Over a median of 17 years of follow-up, there were 2,603 clinical CVD events. Those with the metabolically healthy obese (hazard ratio [HR] 1.38, 95% CI 1.15-1.67), metabolically unhealthy normal weight (HR 1.51, 95% CI 1.30-1.76), metabolically unhealthy overweight (HR 1.60, 95% CI 1.41-1.82), and metabolically unhealthy obese (HR 2.14, 95% CI 1.88-2.44) phenotypes had higher CVD risks in comparison with metabolically healthy normal weight. Detectable hs-cTnT (≥6 ng/L) was associated with higher CVD risk, even among metabolically healthy normal-weight adults. Metabolically healthy obese adults had higher HF risk (HR 1.65, 95% CI 1.30-2.09) in comparison with metabolically healthy normal weight. CONCLUSIONS: The metabolically healthy obese phenotype was associated with excess burden of clinical CVD, primarily driven by an excess risk of HF. hs-cTnT was useful in stratifying CVD risk across all obesity phenotypes, even among obese individuals who appear otherwise metabolically healthy.
引用
- Commodore-Mensah Y, Lazo M, Tang O, et al. High Burden of Subclinical and Cardiovascular Disease Risk in Adults With Metabolically Healthy Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2021. PMID: 33952606. doi:10.2337/dc20-2227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。